Literature DB >> 18295295

Antibody-dependent enhancement of adeno-associated virus infection of human monocytic cell lines.

Seiichiro Mori1, Takamasa Takeuchi, Tadahito Kanda.   

Abstract

In host animals, adeno-associated virus (AAV) is detectable mainly in the lymphoid tissue, which appears to be a target in natural infection. We used the human monocytic cell lines THP-1 and U937 to study the effect of mouse anti-AAV2 antiserum on infection with an AAV2 vector having the luciferase gene (AAV2/Luc). AAV2/Luc was found to infect THP-1 and U937 cells much less efficiently than HeLa cells, as monitored with the induced enzyme activity. Pre-incubation of AAV2/Luc with anti-AAV2 antiserum at a sub-neutralizing concentration enhanced by 2-to-10 fold infection of THP-1 and U937 with AAV2/Luc, but not of HeLa. Similarly, anti-AAV10 serum at a low level enhanced infection of THP-1 with AAV10/Luc. Sera of two cynomolgus monkeys, which had been probably infected with an AAV2-like virus, enhanced infection of THP-1 with AAV2/Luc. The enhancement was reduced with blocking the IgG-receptors Fcgamma-RI and Fcgamma-RII, which were displayed on the surface of THP-1 and U937 but not HeLa cells, with anti-Fcgamma-RI antibody or anti-Fcgamma-RII antibody. The data indicate that infection of Fcgamma receptor-bearing cells with AAV is enhanced by anti-AAV IgG antibodies at a sub-neutralizing concentration that play a role in linking AAV particles and Fcgamma receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295295     DOI: 10.1016/j.virol.2008.01.033

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques.

Authors:  Lili Wang; Roberto Calcedo; Huan Wang; Peter Bell; Rebecca Grant; Luk H Vandenberghe; Julio Sanmiguel; Hiroki Morizono; Mark L Batshaw; James M Wilson
Journal:  Mol Ther       Date:  2009-11-03       Impact factor: 11.454

2.  Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy.

Authors:  Gregory D Hurlbut; Robin J Ziegler; Jennifer B Nietupski; Joseph W Foley; Lisa A Woodworth; Elizabeth Meyers; Scott D Bercury; Nilesh N Pande; David W Souza; Mark P Bree; Michael J Lukason; John Marshall; Seng H Cheng; Ronald K Scheule
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

3.  A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer.

Authors:  Hua Li; Shih-Wen Lin; Wynetta Giles-Davis; Yan Li; Dongming Zhou; Zhi Quan Xiang; Katherine A High; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

4.  A novel mechanism of antibody-mediated enhancement of flavivirus infection.

Authors:  Denise Haslwanter; Dieter Blaas; Franz X Heinz; Karin Stiasny
Journal:  PLoS Pathog       Date:  2017-09-15       Impact factor: 6.823

5.  Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection.

Authors:  Rui-Yuan Cao; Da-Yong Dong; Rui-Ju Liu; Jian-Feng Han; Guang-Chuan Wang; Hui Zhao; Xiao-Feng Li; Yong-Qiang Deng; Shun-Ya Zhu; Xiao-Yu Wang; Fang Lin; Fu-Jun Zhang; Wei Chen; E-De Qin; Cheng-Feng Qin
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

6.  Adeno-associated virus-like particles as new carriers for B-cell vaccines: testing immunogenicity and safety in BALB/c mice.

Authors:  Krisztina Manzano-Szalai; Kathrin Thell; Anna Willensdorfer; Margit Weghofer; Beatrix Pfanzagl; Josef Singer; Mirko Ritter; Caroline Stremnitzer; Ingo Flaschberger; Uwe Michaelis; Erika Jensen-Jarolim
Journal:  Viral Immunol       Date:  2014-09-23       Impact factor: 2.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.